Biopharma Credit
| Type | Public company |
|---|---|
| |
| Industry | Investment trust |
| Founded | 2017 |
| Headquarters | |
| Key people | Harry Hyman (chair) |
Biopharma Credit (LSE: BPCR), is a large British investment trust focused on investments in debt secured on life science products. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.